US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

EQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...

Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

BDR Pharmaceuticals is set to broaden its presence in the US through acquisitions of manufacturing facilities, backed by a $100 million inv...

Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are in competition for a buyout of Farmson Basic Drugs, a leading API make...

US buyout fund Platinum Equity Advisors is in talks to acquire Mumbai-based contract drugmaker Inventia Healthcare at a valuation of ₹2,500...

Several global funds, including Blackstone, Carlyle, PAG, CVC Capital, BPEA EQT, Brookfield Asset Management, and Apax Partners, are intere...

Advent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...

Athenex, which is into the development of cell therapies to treat cancers, had hired investment advisory firm Cowen Inc to run a formal pro...

Dr Reddy's Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the ma...

Founded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical comp...

Set up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderab...

"Ash Stevens will add high potency capabilities to the services we offer our customers," Vivek Sharma, Pharma Solutions business CEO, Piram...

Multinational firms have been usually acquiring Indian drugmakers to expand in the country and leverage their manufacturing facilities.

Private equity fund Actis is looking to purchase more than 25% stake in cortico steroids maker Symbiotec Pharmalab for around $50 million.

The eight proposals that FIPB cleared include those of Pfizer Limited, B Braun, Sutures India and Ordain Health Care Global, government off...

Second-largest overseas buyout by an Indian pharma company will give Sun an edge in North America where Israeli generics player records 90%...